{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:02:22Z","timestamp":1789394542490,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32271387 and 32371454"],"award-info":[{"award-number":["32271387 and 32371454"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["23ZR1465200 and 24ZR1468900"],"award-info":[{"award-number":["23ZR1465200 and 24ZR1468900"]}]},{"name":"Talent Program of Shanghai Municipal Health Commission","award":["2022XD052"],"award-info":[{"award-number":["2022XD052"]}]},{"name":"Sci-Tech Innovation 2030\u2014\u2014Major Project of Brain science and brain-inspired intelligence technology","award":["2021ZD0202003"],"award-info":[{"award-number":["2021ZD0202003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04624-7","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:05:05Z","timestamp":1782576305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guiding off-target nanomedicine repurposing in spleen for cancer immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Caoyi","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"4624_CR1","first-page":"1","volume":"1","author":"AJT Stefan Wilhelm","year":"2016","unstructured":"Stefan Wilhelm AJT, Dai Q, Ohta S, Audet J. D.a.W. C. W. Chan, Analysis of nanoparticle delivery to tumours. Nat Reviews Mater. 2016;1(1):1\u201312.","journal-title":"Nat Reviews Mater"},{"issue":"10","key":"4624_CR2","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","volume":"14","author":"D Sun","year":"2020","unstructured":"Sun D, Zhou S, Gao W. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right. ACS Nano. 2020;14(10):12281\u201390.","journal-title":"ACS Nano"},{"issue":"12","key":"4624_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","volume":"19","author":"B Ouyang","year":"2020","unstructured":"Ouyang B, Poon W, Zhang YN, Lin ZP, Kingston BR, Tavares AJ, Zhang Y, Chen J, Valic MS, Syed AM, MacMillan P, Couture-Senecal J, Zheng G, Chan WCW. The dose threshold for nanoparticle tumour delivery. Nat Mater. 2020;19(12):1362\u201371.","journal-title":"Nat Mater"},{"issue":"1","key":"4624_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66(1):2\u201325.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"4624_CR5","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/pharmaceutics15092233","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Wang Q, Xia G, Adilijiang N, Li Y, Hou Z, Fan Z, Li J. Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. Pharmaceutics. 2023;15(9):2233.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4624_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41565-023-01498-w","volume":"19","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liang Q, Dou J, Zhou H, Zeng C, Pan H, Shen Y, Li Q, Liu Y, Leong DT, Jiang W, Wang Y. Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours. Nat Nanotechnol. 2024;19(1):95\u2013105.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"4624_CR7","doi-asserted-by":"publisher","first-page":"113400","DOI":"10.1016\/j.colsurfb.2023.113400","volume":"228","author":"H Tian","year":"2023","unstructured":"Tian H, Yu L, Zhang M, He J, Sun X, Ni P. Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy. Colloids Surf B Biointerfaces. 2023;228(1):113400.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"9","key":"4624_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","volume":"20","author":"MZ Chen","year":"2025","unstructured":"Chen MZ, Yuen D, McLeod VM, Yong KW, Smyth CH, Herling BR, Payne TJ, Fabb SA, Belousoff MJ, Algarni A, Sexton PM, Porter CJH, Pouton CW, Johnston APR. A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles. Nat Nanotechnol. 2025;20(9):1273\u201384.","journal-title":"Nat Nanotechnol"},{"key":"4624_CR9","doi-asserted-by":"crossref","unstructured":"Saha T, Fojtu M, Nagar AV, Thurakkal L, Srinivasan BB, Mukherjee M, Sibiyon A, Aggarwal H, Samuel A, Dash C, Jang HL, Sengupta S. Antibody nanoparticle conjugate-based targeted immunotherapy for non-small cell lung cancer, Sci Adv 10(24) (2024) eadi2046.","DOI":"10.1126\/sciadv.adi2046"},{"issue":"6","key":"4624_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","volume":"55","author":"SMP Vadevoo","year":"2023","unstructured":"Vadevoo SMP, Gurung S, Lee HS, Gunassekaran GR, Lee SM, Yoon JW, Lee YK, Lee B. Peptides as multifunctional players in cancer therapy. Exp Mol Med. 2023;55(6):1099\u2013109.","journal-title":"Exp Mol Med"},{"issue":"21","key":"4624_CR11","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","volume":"17","author":"M Xu","year":"2023","unstructured":"Xu M, Qi Y, Liu G, Song Y, Jiang X, Du B. Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance. ACS Nano. 2023;17(21):20825\u201349.","journal-title":"ACS Nano"},{"issue":"4","key":"4624_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1023\/A:1012095431931","volume":"14","author":"M Demoy","year":"1997","unstructured":"Demoy M, Gibaud S, Andreux JP, Weingarten C, Gouritin B, Couvreur P. Splenic trapping of nanoparticles: complementary approaches for in situ studies. Pharm Res. 1997;14(4):463\u20138.","journal-title":"Pharm Res"},{"issue":"5","key":"4624_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13346-016-0304-0","volume":"6","author":"AB Jindal","year":"2016","unstructured":"Jindal AB. Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential. Drug Deliv Transl Res. 2016;6(5):473\u201385.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"4624_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.05.008","volume":"130","author":"YS Youn","year":"2018","unstructured":"Youn YS, Bae YH. Perspectives on the past, present, and future of cancer nanomedicine. Adv Drug Deliv Rev. 2018;130(1):3\u201311.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"4624_CR15","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","volume":"52","author":"H He","year":"2019","unstructured":"He H, Liu L, Morin EE, Liu M, Schwendeman A. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures. Acc Chem Res. 2019;52(9):2445\u201361.","journal-title":"Acc Chem Res"},{"issue":"3","key":"4624_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1021\/jacs.5b09974","volume":"138","author":"MW Tibbitt","year":"2016","unstructured":"Tibbitt MW, Dahlman JE, Langer R. Emerging Frontiers in Drug Delivery. J Am Chem Soc. 2016;138(3):704\u201317.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"4624_CR17","doi-asserted-by":"publisher","first-page":"101922","DOI":"10.1016\/j.mtbio.2025.101922","volume":"33","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang X, Tian X, Zhang D, Cui H, Du W, Yang Z, Li J, Li W, Xu J, Duanmu Y, Yu T, Cai F, Li W, Jin Z, Wu W, Huang H. Stealth missiles with precision guidance: A novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology. Mater Today Bio. 2025;33(1):101922.","journal-title":"Mater Today Bio"},{"issue":"11","key":"4624_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010;10(11):753\u201366.","journal-title":"Nat Rev Immunol"},{"issue":"99","key":"4624_CR19","doi-asserted-by":"publisher","first-page":"eadi3487","DOI":"10.1126\/sciimmunol.adi3487","volume":"9","author":"DM Morgan","year":"2024","unstructured":"Morgan DM, Horton BL, Bhandarkar V, Van R, Dinter T, Zagorulya M, Love JC, Spranger S. Expansion of tumor-reactive CD8(+) T cell clonotypes occurs in the spleen in response to immune checkpoint blockade. Sci Immunol. 2024;9(99):eadi3487.","journal-title":"Sci Immunol"},{"issue":"5","key":"4624_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","volume":"20","author":"DJ Irvine","year":"2020","unstructured":"Irvine DJ, Dane EL. Enhancing cancer immunotherapy with nanomedicine. Nat Rev Immunol. 2020;20(5):321\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"4624_CR21","doi-asserted-by":"publisher","first-page":"e2300351","DOI":"10.1002\/adhm.202300351","volume":"12","author":"X He","year":"2023","unstructured":"He X, Wang J, Tang Y, Chiang ST, Han T, Chen Q, Qian C, Shen X, Li R, Ai X. Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy. Adv Healthc Mater. 2023;12(23):e2300351.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"4624_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14(10):986\u201395.","journal-title":"Nat Immunol"},{"issue":"11","key":"4624_CR23","doi-asserted-by":"publisher","first-page":"eadq6399","DOI":"10.1126\/sciadv.adq6399","volume":"11","author":"H An","year":"2025","unstructured":"An H, Huang Y, Zhao Z, Li K, Meng J, Huang X, Tian X, Zhou H, Wu J, Dai Q, Zhang JR. Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice. Sci Adv. 2025;11(11):eadq6399.","journal-title":"Sci Adv"},{"issue":"20","key":"4624_CR24","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1182\/blood-2010-11-320028","volume":"117","author":"TL McGaha","year":"2011","unstructured":"McGaha TL, Chen Y, Ravishankar B, van Rooijen N, Karlsson MC. Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood. 2011;117(20):5403\u201312.","journal-title":"Blood"},{"issue":"4","key":"4624_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2025.02.027","volume":"58","author":"FX Mauvais","year":"2025","unstructured":"Mauvais FX, Hamel Y, Silvin A, Mulder K, Hildner K, Akyol R, Dalod M, Koumantou D, Saveanu L, Garfa M, Cagnard N, Bertocci B, Ginhoux F, van Endert P. Metallophilic marginal zone macrophages cross-prime CD8(+) T cell-mediated protective immunity against blood-borne tumors. Immunity. 2025;58(4):843\u2013e86020.","journal-title":"Immunity"},{"issue":"23","key":"4624_CR26","first-page":"e1706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell Membrane Coat Nanatechnol Adv Mater. 2018;30(23):e1706759.","journal-title":"Cell Membrane Coat Nanatechnol Adv Mater"},{"issue":"26","key":"4624_CR27","doi-asserted-by":"publisher","first-page":"2500446","DOI":"10.1002\/adhm.202500446","volume":"14","author":"Q Cheng","year":"2025","unstructured":"Cheng Q, Zhong X, Deng L, He X, Luo M, Wang R, Zhang J. RBC Membrane-Camouflaged Nanosystem-Mediated Synergistic Drug Combination for Enhanced Anti-Tumor Therapy. Adv Healthc Mater. 2025;14(26):2500446.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"4624_CR28","first-page":"2770","volume":"15","author":"Z Xia","year":"2023","unstructured":"Xia Z, Mu W, Yuan S, Fu S, Liu Y, Zhang N. Cell Membrane Biomim Nano-Delivery Syst Cancer Therapy Pharm. 2023;15(12):2770.","journal-title":"Cell Membrane Biomim Nano-Delivery Syst Cancer Therapy Pharm"},{"issue":"1","key":"4624_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20(1):33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"22","key":"4624_CR30","doi-asserted-by":"publisher","first-page":"14277","DOI":"10.3390\/ijms232214277","volume":"23","author":"X Zhao","year":"2022","unstructured":"Zhao X, Georgieva R, Rerkshanandana P, Hackmann M, Heil Olaizola LE, Muller-de Ahna M. Baumler, Tumor Cell Capture Using Platelet-Based and Platelet-Mimicking Modified Human Serum Albumin Submicron Particles. Int J Mol Sci. 2022;23(22):14277.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4624_CR31","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R, Forghani R, Novobrantseva TI, Koteliansky V, Figueiredo JL, Chen JW, Anderson DG, Nahrendorf M, Swirski FK, Weissleder R, Pittet MJ. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A. 2012;109(7):2491\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4624_CR32","first-page":"5864","volume":"18","author":"J Wu","year":"2024","unstructured":"Wu J, Ma T, Zhu M, Mu J, Huang T, Xu D, Lin N, Gao J. A Pluripotential Neutrophil-Mimic Nanovehicle Modulates Immune Microenvironment with Targeted Drug Delivery for Augmented Antitumor Chemotherapy. ACS Nano. 2024;18(7):5864\u201377.","journal-title":"ACS Nano"},{"issue":"37","key":"4624_CR33","doi-asserted-by":"publisher","first-page":"31124","DOI":"10.1021\/acsami.8b11645","volume":"10","author":"H Zhao","year":"2018","unstructured":"Zhao H, Li L, Zhang J, Zheng C, Ding K, Xiao H, Wang L, Zhang Z, Chemokine C-C. Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer. ACS Appl Mater Interfaces. 2018;10(37):31124\u201335.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4624_CR34","doi-asserted-by":"publisher","first-page":"102116","DOI":"10.1016\/j.mtbio.2025.102116","volume":"34","author":"D Wusiman","year":"2025","unstructured":"Wusiman D, Wang Y, Wang M, Wang J, Wu R, Tuo Z, Wang Z, Yu Q, An Z, Cho WC, Li D, Wei W, Feng D. Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation. Mater Today Bio. 2025;34(1):102116.","journal-title":"Mater Today Bio"},{"issue":"12","key":"4624_CR35","doi-asserted-by":"publisher","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","volume":"15","author":"J Xiong","year":"2021","unstructured":"Xiong J, Wu M, Chen J, Liu Y, Chen Y, Fan G, Liu Y, Cheng J, Wang Z, Wang S, Liu Y, Zhang W. Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer. ACS Nano. 2021;15(12):19756\u201370.","journal-title":"ACS Nano"},{"issue":"10","key":"4624_CR36","doi-asserted-by":"publisher","first-page":"eaaw6870","DOI":"10.1126\/sciadv.aaw6870","volume":"5","author":"X Han","year":"2019","unstructured":"Han X, Shen S, Fan Q, Chen G, Archibong E, Dotti G, Liu Z, Gu Z, Wang C. Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy. Sci Adv. 2019;5(10):eaaw6870.","journal-title":"Sci Adv"},{"issue":"6","key":"4624_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1021\/acsmaterialslett.0c00044","volume":"2","author":"YN Lin","year":"2020","unstructured":"Lin YN, Elsabahy M, Khan S, Zhang FW, Song Y, Dong M, Li RC, Smolen J, Letteri RA, Su L, Wooley KL. Erythrocyte-Membrane-Camouflaged Nanocarriers with Tunable Paclitaxel Release Kinetics via Macromolecular Stereocomplexation. Acs Mater Lett. 2020;2(6):595\u2013601.","journal-title":"Acs Mater Lett"},{"issue":"43","key":"4624_CR38","doi-asserted-by":"publisher","first-page":"37954","DOI":"10.1021\/acsnano.5c12737","volume":"19","author":"Y Ye","year":"2025","unstructured":"Ye Y, Wang H, Jiang J, Cao X, Sun J, Jiang Y, Liu L, Huang W, Tian H, Yang Y, Peng F, Wen L. Tu, Biomimetic Self-Guiding Nanomotors Boost Active Immunotherapy. ACS Nano. 2025;19(43):37954\u201371.","journal-title":"ACS Nano"},{"issue":"1","key":"4624_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood-2019-131390","volume":"134","author":"SS Pei","year":"2019","unstructured":"Pei SS, Pollyea DA, Gustafson A, Minhajuddin M, Stevens BM, Ye HB, Inguva A, Amaya ML, Krug A, Jones CL, Adane B, Winters A, Khan N, Ponder J, Schowinsky J, Hammes A, Abbott D, Myers JR, Ashton JM, Gutman JA, Purev E, Ramsey HE, Savona MR, Fesik SW, Smith C, Jordan CT. Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy. Blood. 2019;134(1):185.","journal-title":"Blood"},{"issue":"2","key":"4624_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1189\/jlb.0210112","volume":"88","author":"SM Rankin","year":"2010","unstructured":"Rankin SM. The bone marrow: a site of neutrophil clearance. J Leukoc Biol. 2010;88(2):241\u201351.","journal-title":"J Leukoc Biol"},{"issue":"5\u20136","key":"4624_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1159\/000335216","volume":"4","author":"JM den Haan","year":"2012","unstructured":"den Haan JM, Kraal G. Innate immune functions of macrophage subpopulations in the spleen. J Innate Immun. 2012;4(5\u20136):437\u201345.","journal-title":"J Innate Immun"},{"key":"4624_CR42","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","volume":"19","author":"B Ouyang","year":"2020","unstructured":"Ouyang B, Poon W, Zhang Y-N, Lin ZP, Kingston BR, Tavares AJ, Zhang Y, Chen J, Valic MS, Syed AM, MacMillan P, Couture-Sen\u00e9cal J, Zheng G, Chan WCW. The dose threshold for nanoparticle tumour delivery. Nat Mater. 2020;19:1362\u201371.","journal-title":"Nat Mater"},{"issue":"3","key":"4624_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0962-8924(00)01906-1","volume":"11","author":"EJ Brown","year":"2001","unstructured":"Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001;11(3):130\u20135.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4624_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-020-00989-w","volume":"13","author":"TC Kuo","year":"2020","unstructured":"Kuo TC, Chen A, Harrabi O, Sockolosky JT, Zhang AL, Sangalang E, Doyle L, Kauder SE, Fontaine D, Bollini S, Han B, Fu YX, Sim J, Pons J, Wan H. Targeting the myeloid checkpoint receptor SIRP\u03b1 potentiates innate and adaptive immune responses to promote anti-tumor activity. J Hematol Oncol. 2020;13(1):160.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4624_CR45","first-page":"73","volume":"8","author":"TR Klei","year":"2017","unstructured":"Klei TR, Meinderts SM, van den Berg TK, van Bruggen R. From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis. Front Immunol. 2017;8(1):73.","journal-title":"Front Immunol"},{"key":"4624_CR46","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte V, Pittet MJ. The Spleen in Local and Systemic Regulation of Immunity. Immunity. 2013;39:806\u201318.","journal-title":"Immunity"},{"key":"4624_CR47","first-page":"385","volume":"29","author":"J Higashijima","year":"2009","unstructured":"Higashijima J, Shimada M, Chikakiyo M, Miyatani T, Yoshikawa K, Nishioka M, Iwata T, Kurita N. Effect of Splenectomy on Antitumor Immune System in Mice. Anticancer Res. 2009;29:385\u201393.","journal-title":"Anticancer Res"},{"key":"4624_CR48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.celrep.2012.08.006","volume":"2","author":"S Ugel","year":"2012","unstructured":"Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V. Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen. Cell Rep. 2012;2:628\u201339.","journal-title":"Cell Rep"},{"key":"4624_CR49","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1177\/0192623310386499","volume":"38","author":"B Thoolen","year":"2010","unstructured":"Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, Malarkey DE, Kaufmann W, K\u00fcttler K, Deschl U, Nakae D, Gregson R, Vinlove MP, Brix AE, Singh B, Belpoggi F, Ward JM. Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System. Toxicol Pathol. 2010;38:S5\u201381.","journal-title":"Toxicol Pathol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04624-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:02:37Z","timestamp":1789390957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04624-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4624"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04624-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"865"}}